Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus

被引:67
作者
Sukhija, Rishi
Aronow, Wilbert S.
Kakar, Priyanka
Garza, Luis
Sachdeva, Rajesh
Sinha, Anjan
Mehta, Jawahar L. [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA
[3] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA
[4] New York Med Coll, Div Cardiol, Valhalla, NY 10595 USA
关键词
D O I
10.1016/j.amjcard.2006.01.098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microalbuminuria (MA) is a well-known risk factor for coronary artery disease (CAD) in diabetics and nondiabetics. It is associated with higher cardiovascular mortality, especially in diabetics. However, there are few data linking angiographic severity of CAD to microalbuminuria. We examined coronary angiograms for extent of severe CAD (luminal narrowing >= 50%) in patients with type 2 diabetes mellitus (DM) and MA (DM(+)MA(+), n = 101), patients with DM and without MA (DM(+)MA(-), n = 101), patients without DM and with MA (DM(-)MA(+), n = 64), and patients without DM and MA (DM(-)MA(-), n = 64). We also evaluated fasting glucose levels in all patients and glycosylated hemoglobin in diabetics. Patients' mean age in the DM(+)MA(+), DM(+)MA(-), DM(-)MA(+), and DM(-)MA(-) groups was similar. Gender distribution across the 4 groups was also not significantly different. There were no significant differences in the prevalence of hypertension, hypercholesterolemi, and current smoking across the 4 groups. The presence of 2- or 3-vessel CAD showed a linear increase from group DM-MA- to group DM(+)MA(+) (p < 0.001). Diabetics with MA had higher fasting glucose and glycosylated hemoglobin levels than diabetics without MA (p < 0.001). Thus, patients with MA have more severe angiographic CAD than those without MA. This relation is independent of other risk factors and is particularly evident in patients with DM. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:279 / 281
页数:3
相关论文
共 20 条
[1]   Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].
Asselbergs, FW ;
Diercks, GFH ;
Hillege, HL ;
van Boven, AJ ;
Janssen, WMT ;
Voors, AA ;
de Zeeuw, D ;
de Jong, PE ;
van Veldhuisen, DJ ;
van Gilst, WH .
CIRCULATION, 2004, 110 (18) :2809-2816
[2]  
Clausen P, 2001, CIRCULATION, V103, P1869
[3]   Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes [J].
Diercks, GFH ;
Hillege, HL ;
van Boven, AJ ;
Kors, JA ;
Crijns, HJGM ;
Grobbee, DE ;
de Jong, PE ;
van Gilst, WH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (08) :1401-1407
[4]   Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [J].
Eknoyan, G ;
Hostetter, T ;
Bakris, GL ;
Hebert, L ;
Levey, AS ;
Parving, HH ;
Steffes, MW ;
Toto, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (04) :617-622
[5]   Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects:: The Insulin Resistance Atherosclerosis Study [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1703-1710
[6]   Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].
Gerstein, HC ;
Mann, JFE ;
Yi, QL ;
Zinman, B ;
Dinneen, SF ;
Hoogwerf, B ;
Hallé, JP ;
Young, J ;
Rashkow, A ;
Joyce, C ;
Nawaz, S ;
Yusuf, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426
[7]   Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population [J].
Hillege, HL ;
Fidler, V ;
Diercks, GFH ;
van Gilst, WH ;
de Zeeuw, D ;
van Veldhuisen, DJ ;
Gans, ROB ;
Janssen, WMT ;
Grobbee, DE ;
de Jong, PE .
CIRCULATION, 2002, 106 (14) :1777-1782
[8]   Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy?: A LIFE substudy [J].
Ibsen, H ;
Wachtell, K ;
Olsen, MH ;
Borch-Johnsen, K ;
Lindholm, LH ;
Mogensen, CE ;
Dahlöf, B ;
Devereux, RB ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wan, Y .
JOURNAL OF HYPERTENSION, 2004, 22 (09) :1805-1811
[9]   Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients -: Losartan intervention for endpoint reduction in hypertension study [J].
Ibsen, H ;
Olsen, MH ;
Wachtell, K ;
Borch-Johnsen, K ;
Lindholm, LH ;
Mogensen, CE ;
Dahlöf, B ;
Devereux, RB ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wan, Y .
HYPERTENSION, 2005, 45 (02) :198-202
[10]   Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease [J].
Kanaya, AM ;
Herrington, D ;
Vittinghoff, E ;
Lin, F ;
Bittner, V ;
Cauley, JA ;
Hulley, S ;
Barrett-Connor, E .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) :813-820